Ignite Creation Date:
2024-05-05 @ 4:43 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00303550
Status:
COMPLETED
Last Update Posted:
2007-03-27
First Post:
2006-03-15
Brief Title:
Study of Intravenous IV Iclaprim Versus Linezolid in Complicated Skin and Skin Structure Infections cSSSI ASSIST-2
Sponsor:
Arpida AG
Organization:
Arpida AG
Organization Data
Organization:
Arpida AG
Class:
INDUSTRY
Study ID:
Protocol No ICLA-09-CSI2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Arpida AG
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None